InvestorsObserver
×
News Home

Should Biotechnology Stock Caribou Biosciences Inc (CRBU) Be in Your Portfolio Friday?

Friday, November 24, 2023 12:30 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Caribou Biosciences Inc (CRBU) Be in Your Portfolio Friday?

The 58 rating InvestorsObserver gives to Caribou Biosciences Inc (CRBU) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 74 percent of stocks in the Biotechnology industry, CRBU’s 58 overall rating means the stock scores better than 58 percent of all stocks.

Overall Score - 58
CRBU has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on CRBU!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Caribou Biosciences Inc Stock Today?

Caribou Biosciences Inc (CRBU) stock is trading at $5.67 as of 12:29 PM on Friday, Nov 24, a decline of -$0.02, or -0.37% from the previous closing price of $5.69. Volume today is below average. So far 701,147 shares have traded compared to average volume of 1,707,675 shares. The stock has traded between $5.65 and $5.94 so far today. Click Here to get the full Stock Report for Caribou Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App